Regeneron Pharmaceuticals(REGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

REGN Regeneron Pharmaceuticals

Trading 04-06 13:11:56 EDT

762.09

+0.24

+0.03%

High768.80	Low759.72	Vol178.46K
Open766.74	D1 Closing761.85	Amplitude1.19%
Mkt Cap80.57B	Tradable Cap78.73B	Total Shares105.72M
T/O136.46M	T/O Rate0.17%	Tradable Shares103.30M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"REGN","market":"US","secType":"STK","nameCN":"Regeneron Pharmaceuticals","latestPrice":762.09,"timestamp":1775495511030,"preClose":761.85,"halted":0,"volume":178462,"delay":0,"changeRate":0.0003150226422524238,"floatShares":103302739,"shares":105719806,"eps":41.59414,"marketStatus":"Trading","change":0.24,"latestTime":"04-06 13:11:56 EDT","open":766.74,"high":768.8,"low":759.7175,"amount":136457309.829,"amplitude":0.011922,"askPrice":762.76,"askSize":426,"bidPrice":761.41,"bidSize":172,"shortable":3,"etf":0,"ttmEps":41.59414,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1775505600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":761.85,"dividendRate":0.004698,"preHourTrading":{"tag":"盘前","latestPrice":760.01,"preClose":761.85,"latestTime":"09:25 EDT","volume":92,"amount":70085.807,"timestamp":1775481916778,"change":-1.84,"changeRate":-0.002415,"amplitude":0.016631},"postHourTrading":{"tag":"盘后","latestPrice":761.54,"preClose":761.85,"latestTime":"19:34 EDT","volume":14014,"amount":10675810.7376,"timestamp":1775172869948,"change":-0.31,"changeRate":-0.000407,"amplitude":0.000407},"volumeRatio":0.461705,"impliedVol":0.4773,"impliedVolPercentile":0.94},"requestUrl":"/m/hq/s/REGN","defaultTab":"news","newsList":[{"id":"2625322617","title":"Regeneron’s EYLEA HD Label Update Shifts Retinal Care And Competition","url":"https://stock-news.laohu8.com/highlight/detail?id=2625322617","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625322617?lang=en_us&edition=fundamental","pubTime":"2026-04-05 07:28","pubTimestamp":1775345297,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals (NasdaqGS:REGN) received FDA approval to extend EYLEA HD dosing intervals for wet age-related macular degeneration and diabetic macular edema up to every 20 weeks.\nThe decision is based on two year efficacy and safety data and updates the product label to reflect longer potential intervals between injections.\nThe change may reduce treatment burden for eligible patients and could influence how eye specialists plan long term care for wAMD and DME.\n\nRegeneron enters...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/regenerons-eylea-hd-label-update-shifts-retinal-care-and-com","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/regenerons-eylea-hd-label-update-shifts-retinal-care-and-com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0943347566.SGD","BK4566","LU2237438978.USD","LU0868494617.USD","LU2362541273.HKD","LU1778281490.HKD","LU0058720904.USD","LU0820562030.AUD","LU0289739699.SGD","LU0114720955.EUR","BK4533","LU0823411888.USD","BK4585","LU0823434583.USD","LU1496350502.SGD","LU1989772840.SGD","LU2756315664.SGD","BK4567","LU1551013425.SGD","BK4083","LU0882574055.USD","REGN","LU1236620834.HKD","LU0079474960.USD","LU1674673691.USD","BK4550","LU0942090050.USD","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU0234572021.USD","IE00B1XK9C88.USD","SG9999001440.SGD","LU2362541513.USD","LU1929549753.HKD","LU0868494708.USD","LU1674673428.USD","LU2106854487.HKD","LU0354030438.USD","BK4139","LU2361045086.USD","LU0689472784.USD","LU1974910355.USD","IE00BWXC8680.SGD","LU2361044865.SGD","HD","LU1093756325.SGD","LU0889565916.HKD","LU2756315318.SGD","IE00BSNM7G36.USD","LU0238689110.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624661094","title":"Regeneron director Arthur Ryan reports REGN share sale worth $0 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624661094","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624661094?lang=en_us&edition=fundamental","pubTime":"2026-04-04 04:02","pubTimestamp":1775246554,"startTime":"0","endTime":"0","summary":"Regeneron director Arthur Ryan reported sale of 100 shares of common stock on April 1, 2026.Transaction prices ranged from USD 771.32 to USD 779.71 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regeneron Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 03, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nNDL2RZXnN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Regeneron director Arthur Ryan reports REGN share sale worth $0 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU2468319806.SGD","BK4585","LU2023250504.SGD","LU0109394709.USD","LU2089984988.USD","LU2362540622.SGD","REGN","LU2106854487.HKD","LU0320765992.SGD","LU2237438978.USD","LU0823416689.USD","LU0053666078.USD","LU0058720904.USD","BK4588","LU2362541513.USD","BK4139","LU0114720955.EUR","LU0289739699.SGD","LU0889565916.HKD","LU1917777945.USD","LU1974910355.USD","LU2362541273.HKD","LU0823434583.USD","LU0823434740.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156527754","title":"Trump Will Impose 100% Tariff on Some Patented Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=1156527754","media":"Tiger Newspress","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156527754?lang=en_us&edition=fundamental","pubTime":"2026-04-03 07:16","pubTimestamp":1775171812,"startTime":"0","endTime":"0","summary":"The Trump administration will impose tariffs of as much as 100% on certain imported medicines, albeit with several major exemptions, a maneuver to pressure drugmakers to manufacture more in the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"4e63e9b5baa83146ad37e2bf910d1394","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VIR","ABBV","GSK","ABT","BNTX","PFE","NVAX","AMGN","MRK","NVO","REGN","MRNA","NVS","SNY","JNJ","BMY","AZN","GILD","BIIB","VERU","LLY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624680582","title":"BRIEF-Trinetx Collaborates With Regeneron To Access De-Identified Electronic Health Records Of 300 Million Patients To Drive Research And Product Development In Life Sciences And Digital Health Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2624680582","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624680582?lang=en_us&edition=fundamental","pubTime":"2026-04-03 05:31","pubTimestamp":1775165475,"startTime":"0","endTime":"0","summary":"BRIEF-Trinetx Collaborates With Regeneron To Access De-Identified Electronic Health Records Of 300 Million Patients To Drive Research And Product Development In Life Sciences And Digital Health Soluti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nTUABCPWKL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1974910355.USD","LU2089984988.USD","LU0053666078.USD","LU2468319806.SGD","BK4588","LU2362541273.HKD","LU2023250504.SGD","LU0823434740.USD","LU0109394709.USD","LU0889565916.HKD","LU0882574055.USD","LU0289739699.SGD","LU2362540622.SGD","LU2106854487.HKD","REGN","LU0320765992.SGD","LU0114720955.EUR","LU0823434583.USD","LU2237438978.USD","BK4139","LU2362541513.USD","LU1917777945.USD","LU0058720904.USD","BK4585","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624368785","title":"Regeneron to invest up to $200M in TriNetX as part of strategic collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2624368785","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624368785?lang=en_us&edition=fundamental","pubTime":"2026-04-03 04:35","pubTimestamp":1775162141,"startTime":"0","endTime":"0","summary":"TriNetX and Regeneron (REGN) Pharmaceuticals announced a strategic collaboration to support Regeneron’s capabilities in drug discovery and developm...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regeneron-to-invest-up-to-200m-in-trinetx-as-part-of-strategic-collaboration-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regeneron-to-invest-up-to-200m-in-trinetx-as-part-of-strategic-collaboration-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0058720904.USD","LU0109394709.USD","LU2237438978.USD","LU2362541273.HKD","LU0889565916.HKD","LU0114720955.EUR","LU1974910355.USD","REGN","LU1917777945.USD","LU0053666078.USD","LU0320765992.SGD","LU2106854487.HKD","LU2468319806.SGD","LU0823434740.USD","LU0289739699.SGD","LU2362541513.USD","LU0882574055.USD","LU2089984988.USD","BK4588","LU0823416689.USD","BK4585","LU0823434583.USD","BK4139","LU2362540622.SGD","LU2023250504.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624568245","title":"Regeneron, TriNetX partner to link genomic data with EHRs from 300 million patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2624568245","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624568245?lang=en_us&edition=fundamental","pubTime":"2026-04-03 04:31","pubTimestamp":1775161883,"startTime":"0","endTime":"0","summary":"Regeneron entered strategic collaboration with TriNetX to access de-identified electronic health records data covering about 300 million patients.Deal grants Regeneron exclusive opportunity to link its genomic and proteomic cohorts with TriNetX phenotypic network to expand its EHR-linked molecular database.TriNetX will provide licensed access to current and future de-identified data, including about 170 million US patients.Regeneron plans to use expanded dataset to support drug discovery, development programs, AI training, digital health initiatives.Regeneron will invest up to 200 million in TriNetX.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL8dYbhF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0109394709.USD","LU0053666078.USD","LU2362541273.HKD","LU0823434583.USD","LU2106854487.HKD","LU0320765992.SGD","LU0823416689.USD","LU2362540622.SGD","LU0289739699.SGD","LU0889565916.HKD","LU1917777945.USD","LU0882574055.USD","BK4585","LU2468319806.SGD","LU2023250504.SGD","REGN","LU2089984988.USD","LU2362541513.USD","LU2237438978.USD","LU0823434740.USD","LU1974910355.USD","LU0058720904.USD","LU0114720955.EUR","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624682467","title":"Regeneron Pharmaceuticals Inc: as Part of Collaboration, Regeneron Will Invest up to $200 Mln in Trinetx","url":"https://stock-news.laohu8.com/highlight/detail?id=2624682467","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624682467?lang=en_us&edition=fundamental","pubTime":"2026-04-03 04:30","pubTimestamp":1775161800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nTUABCPWKL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","LU0823434583.USD","LU0114720955.EUR","LU2362541513.USD","LU0289739699.SGD","LU1974910355.USD","LU2468319806.SGD","BK4588","LU0053666078.USD","LU0823416689.USD","BK4139","LU0320765992.SGD","LU2362540622.SGD","REGN","LU2237438978.USD","LU0889565916.HKD","LU0882574055.USD","LU2106854487.HKD","LU1917777945.USD","LU0823434740.USD","LU2089984988.USD","LU0058720904.USD","LU0109394709.USD","LU2023250504.SGD","LU2362541273.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624682113","title":"Trinetx Collaborates With Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2624682113","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624682113?lang=en_us&edition=fundamental","pubTime":"2026-04-03 04:30","pubTimestamp":1775161800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nTUABCPWKL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4139","LU0823434740.USD","LU0823434583.USD","LU2106854487.HKD","LU2362540622.SGD","LU0289739699.SGD","LU0320765992.SGD","LU0823416689.USD","LU2468319806.SGD","LU2023250504.SGD","LU0889565916.HKD","LU1974910355.USD","LU0109394709.USD","REGN","LU0058720904.USD","LU2089984988.USD","LU2362541513.USD","LU0882574055.USD","LU0053666078.USD","BK4585","LU2362541273.HKD","LU1917777945.USD","LU0114720955.EUR","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624689371","title":"Regeneron Says It Expects to Be Exempt From the Pharma Tariffs That It Hears Are Being Announced Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2624689371","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624689371?lang=en_us&edition=fundamental","pubTime":"2026-04-03 02:01","pubTimestamp":1775152916,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nFWN40L0J8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0289739699.SGD","LU2089984988.USD","BK4588","LU0320765992.SGD","LU2023250504.SGD","LU0109394709.USD","LU2106854487.HKD","LU0823434583.USD","LU2362541273.HKD","LU0114720955.EUR","BK4139","LU0882574055.USD","LU1974910355.USD","REGN","LU2468319806.SGD","LU2237438978.USD","LU0823434740.USD","LU0053666078.USD","BK4585","LU2362540622.SGD","LU1917777945.USD","LU0889565916.HKD","LU2362541513.USD","LU0058720904.USD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624168958","title":"Regeneron Says It Expects to Announce an Mfn Agreement in the Near Future","url":"https://stock-news.laohu8.com/highlight/detail?id=2624168958","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624168958?lang=en_us&edition=fundamental","pubTime":"2026-04-03 02:01","pubTimestamp":1775152916,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nFWN40L0J8:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2023250504.SGD","LU0320765992.SGD","LU1974910355.USD","LU0882574055.USD","REGN","LU1917777945.USD","LU0823434583.USD","LU2362541513.USD","BK4588","LU2362540622.SGD","LU0823416689.USD","LU0109394709.USD","LU0114720955.EUR","LU2362541273.HKD","LU2106854487.HKD","LU2468319806.SGD","LU0823434740.USD","LU0289739699.SGD","LU0889565916.HKD","LU0058720904.USD","LU0053666078.USD","BK4585","LU2089984988.USD","LU2237438978.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624531685","title":"BRIEF-Eylea HD Approved By FDA As First And Only Injectable Anti-Vegf With Dosing Intervals Up To 5 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2624531685","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624531685?lang=en_us&edition=fundamental","pubTime":"2026-04-03 00:36","pubTimestamp":1775147760,"startTime":"0","endTime":"0","summary":"BRIEF-Eylea HD Approved By FDA As First And Only Injectable Anti-Vegf With Dosing Intervals Up To 5 Months April 2 (Reuters) - Regeneron Pharmaceuticals Inc REGN.O:EYLEA HD (AFLIBERCEPT) APPROVED BY F","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nTUA4D6F0T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN","LU2362541513.USD","LU1917777945.USD","LU0823416689.USD","LU0053666078.USD","LU0882574055.USD","LU0823434740.USD","LU0114720955.EUR","LU2023250504.SGD","BK4139","BK4585","LU2468319806.SGD","LU2089984988.USD","LU0320765992.SGD","LU2237438978.USD","LU0889565916.HKD","LU0109394709.USD","LU0823434583.USD","LU2362540622.SGD","LU2362541273.HKD","LU0289739699.SGD","LU0058720904.USD","LU1974910355.USD","LU2106854487.HKD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624845685","title":"Regeneron Gets FDA OK for Extended Eylea HD Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2624845685","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624845685?lang=en_us&edition=fundamental","pubTime":"2026-04-03 00:29","pubTimestamp":1775147340,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals has won Food and Drug Administration approval of extended dosing intervals of up to every 20 weeks for its Eylea HD eye drug.Regeneron on Thursday said the extended dosing covers patients with wet age-related macular degeneration and diabetic macular edema following one year of successful response based on visual and anatomic outcomes.The Tarrytown, N.Y., biotechnology company said the new dosing regimen allows patients to be treated as infrequently as two to three times a year, further extending the widest range of dosing intervals of any approved injectable anti-vascular endothelial growth factor, or anti-VEGF, therapy.Eylea HD generated U.S. sales of nearly $1.64 billion last year.Regeneron, which develops the Eylea franchise with Germany's Bayer, maintains exclusive rights to the products in the U.S., while Bayer has licensed the exclusive marketing rights outside the U.S., where the companies equally split profits from sales.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0238689110.USD","LU0098860793.USD","LU2468319806.SGD","LU0234572021.USD","LU1929549753.HKD","LU2361044949.HKD","LU0820562030.AUD","IE00BSNM7G36.USD","BK4139","LU0320765992.SGD","LU1093756168.USD","LU2461242641.AUD","LU1496350171.SGD","LU0823434740.USD","BK4566","BK4581","IE00BZ1G4Q59.USD","LU0823416689.USD","LU0868494617.USD","LU1162221912.USD","IE00BWXC8680.SGD","LU2361045086.USD","LU0354030511.USD","LU0882574055.USD","LU1236620750.USD","LU2106854487.HKD","LU2756315664.SGD","LABU","BK4585","REGN","LU0942090050.USD","LU0320765646.SGD","LU0823434583.USD","LU1236620834.HKD","HD","LU0689472784.USD","LU2362541273.HKD","LU1496350502.SGD","BK4083","LU1778281490.HKD","LU2089984988.USD","LU1674673428.USD","LU0354030438.USD","LU2361044865.SGD","BK4588","LU0053666078.USD","LU1974910355.USD","LU1989772840.SGD","IE00BKVL7J92.USD","LU0820561818.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624468377","title":"Regeneron announces FDA approval of extension of dosing intervals for EYLEA HD","url":"https://stock-news.laohu8.com/highlight/detail?id=2624468377","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624468377?lang=en_us&edition=fundamental","pubTime":"2026-04-03 00:06","pubTimestamp":1775145977,"startTime":"0","endTime":"0","summary":"Regeneron (REGN) Pharmaceuticals announced that the U.S. Food and Drug Administration has approved the extension of dosing intervals for EYLEA HD u...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regeneron-announces-fda-approval-of-extension-of-dosing-intervals-for-eylea-hd-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regeneron-announces-fda-approval-of-extension-of-dosing-intervals-for-eylea-hd-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1974910355.USD","LU0098860793.USD","LU0053666078.USD","LU0868494617.USD","LU1914381329.SGD","LU2468319806.SGD","BK4588","LU2362541273.HKD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU0868494708.USD","LU0320765646.SGD","LU0820561818.USD","LU1236620750.USD","BK4567","LU0689472784.USD","LU0943347566.SGD","LU0823434740.USD","LU1035775433.USD","LU0882574055.USD","LU0289739699.SGD","LU1236620834.HKD","HD","LU1093756168.USD","BK4534","LU2106854487.HKD","LU1551013425.SGD","SG9999001440.SGD","REGN","BK4504","LU2361045086.USD","LU1929549753.HKD","LU0114720955.EUR","BK4083","BK4581","LU1093756325.SGD","LU1989772840.SGD","IE00B1XK9C88.USD","LU0354030438.USD","LABU","BK4139","LU2361044949.HKD","LU2362541513.USD","LU1674673428.USD","LU2461242641.AUD","LU1917777945.USD","LU1496350171.SGD","LU1162221912.USD","LU0942090050.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624683309","title":"Eylea Hd® (Aflibercept) Approved by FDA as First and Only Injectable Anti-Vegf With Dosing Intervals up to 5 Months for Wet Age-Related Macular Degeneration (Wamd) and Diabetic Macular Edema (Dme)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624683309","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624683309?lang=en_us&edition=fundamental","pubTime":"2026-04-03 00:00","pubTimestamp":1775145601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nTUA4D6F0T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0823434740.USD","LU2237438978.USD","LU2362541273.HKD","LU0053666078.USD","LU0882574055.USD","BK4585","LU2106854487.HKD","REGN","LU0058720904.USD","LU2089984988.USD","LU0823416689.USD","LU0320765992.SGD","LU2468319806.SGD","LU0114720955.EUR","BK4588","LU0823434583.USD","LU2362540622.SGD","BK4139","LU0289739699.SGD","LU2362541513.USD","LU0889565916.HKD","LU1917777945.USD","LU1974910355.USD","LU2023250504.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624683305","title":"Regeneron Pharmaceuticals Inc - FDA Target Action Date in April 2026 for Eylea Hd Prefilled Syringe","url":"https://stock-news.laohu8.com/highlight/detail?id=2624683305","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624683305?lang=en_us&edition=fundamental","pubTime":"2026-04-03 00:00","pubTimestamp":1775145601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nTUA4D6F0T:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2468319806.SGD","BK4139","LU0320765992.SGD","LU0109394709.USD","LU0823434740.USD","LU0114720955.EUR","LU0823416689.USD","LU2106854487.HKD","BK4585","LU2362541513.USD","REGN","LU0823434583.USD","LU0289739699.SGD","LU2362540622.SGD","LU2362541273.HKD","LU0058720904.USD","LU0889565916.HKD","LU2023250504.SGD","LU2089984988.USD","LU1917777945.USD","BK4588","LU0053666078.USD","LU1974910355.USD","LU2237438978.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624683277","title":"EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624683277","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624683277?lang=en_us&edition=fundamental","pubTime":"2026-04-03 00:00","pubTimestamp":1775145600,"startTime":"0","endTime":"0","summary":"Approval is based on 96-week data from 2 pivotal trials showing majority of EYLEA HD patients maintained their visual and anatomic improvements with extended dosing intervals New EYLEA HD dosing regim","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/02/3267657/0/en/EYLEA-HD-aflibercept-Approved-by-FDA-as-First-and-Only-Injectable-Anti-VEGF-with-Dosing-Intervals-Up-to-5-Months-for-Wet-Age-related-Macular-Degeneration-wAMD-and-Diabetic-Macular-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMUU","LU1712237335.SGD","LU1633808545.USD","LU1988902786.USD","AMDG","DAMD","BK4534","LU2506952170.USD","LU0109394709.USD","LU2023250504.SGD","LU0823434583.USD","LU1674673691.USD","LU0114720955.EUR","LU0056508442.USD","BK4512","AMYY","BK4612","LU1093756325.SGD","BK4529","LU2054465674.USD","LU0234572021.USD","IE00BMPRXN33.USD","IE00BSNM7G36.USD","LU0820561818.USD","IE0004445239.USD","LU0238689110.USD","LU0274383776.USD","LU2237438978.USD","LU0058720904.USD","LU2355687059.USD","LU1236620834.HKD","IE0009356076.USD","LU0289739699.SGD","LU0053666078.USD","LU2361044865.SGD","LU2458330243.SGD","LU1069344957.HKD","LU0320765992.SGD","LU2106854487.HKD","LU1989764664.SGD","AMDY","LU1917777945.USD","BK4567","BK4573","LU1951200564.SGD","AMDD","BK4083","BK4206","BK4543","LU0823411888.USD","LU1951198990.SGD","LU2756315664.SGD","LU0820561909.HKD","BK4575","LU1303367103.USD","LU0889565916.HKD","LU0823421416.USD","LU1623119135.USD","LU0354030438.USD","IE00B1XK9C88.USD","LU2361044949.HKD","BK4588","IE00BQXX3F31.USD","BK4581","LU0823434740.USD","LU1242518931.SGD","LU0942090050.USD","LU0642271901.SGD","BK4554","LU0979878070.USD","LU0390134368.USD","LU2362541513.USD","LU1880398554.USD","LU2506951875.HKD","BK4566","LU1989772840.SGD","IE00BWXC8680.SGD","SG9999001440.SGD","LU1430594728.SGD","LU0079474960.USD","IE00BMPRXR70.SGD","LU2250418816.HKD","LU0354030511.USD","LU0882574055.USD","LU0868494708.USD","BK4550","LU0689472784.USD","BK4023","LU1585245621.USD","LU2756315318.SGD","LU2468319806.SGD","LU0081259029.USD","LU2360106780.USD","LU0823416689.USD","LU0823421333.USD","BK4504","LU1496350502.SGD","AMDW","IE00BZ1G4Q59.USD","BK4139","LU1861558580.USD","IE00BKVL7J92.USD","LU2264538146.SGD","LU2089984988.USD","LU2458330169.SGD","BK4585","LU1236620750.USD","AMDL","LU2461242641.AUD","LU0950375773.USD","LU2098885051.SGD","LU1496350171.SGD","LU1803068979.SGD","LU2506952097.USD","LU1989772923.USD","IE00BQXX3C00.GBP","LU0320765646.SGD","LU0342679015.USD","BK4614","LU0127658192.USD","BK4605","LU1316542783.SGD","LU1093756168.USD","LU1162221912.USD","LU1929549753.HKD","IE00BQXX3D17.EUR","LU0868494617.USD","IE00B5949003.HKD","LU1242518857.USD","LU1914381329.SGD","LU0082616367.USD","LU1035775433.USD","LU1064131342.USD","LU0719512351.SGD","BK4533","LU0943347566.SGD","AMDU","IE0008368304.USD","LU2931357623.SGD","BK4532","LU1674673428.USD","LU0823417737.USD","LU1880398471.USD","REGN","LU1551013342.USD","LU0098860793.USD","LU0823417653.USD","LU0889565833.HKD","LU2361045086.USD","BK4141","LU1923623000.USD","LU1551013425.SGD","LU1974910355.USD","LU0109392836.USD","LU2362540622.SGD","LU0198837287.USD","LU1778281490.HKD","LU0820562030.AUD","LU2362541273.HKD","LU2506951958.HKD","LU1861559042.SGD","LU2089985449.USD","LU1852331112.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624500129","title":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-04-02","url":"https://stock-news.laohu8.com/highlight/detail?id=2624500129","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624500129?lang=en_us&edition=fundamental","pubTime":"2026-04-02 23:01","pubTimestamp":1775142067,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-04-02Nasdaq 100 .NDXTop PerformersPercent ChangeIntel Corp INTC.OQ+3.2%DoorDash Inc DASH.OQ+2.5%Diamondback Energy Inc FANG.OQ+2.5%Netflix Inc NFLX.OQ+1.8%Cisco Systems Inc CSCO.OQ+1.5%Bottom PerformersPercent ChangeArm Holdings PLC ARM.OQ-5.3%Tesla Inc TSLA.OQ-4.0%Regeneron Pharmaceuticals Inc REGN.OQ-2.6%Western Digital Corp WDC.OQ-2.3%Axon Enterprise Inc AXON.OQ-2.3%The Nasdaq 100 .NDX lost 61.61 points, or 0.26%, to 23,958.38 and recorded no new highs and one new low. 51 stocks rose and 50 fell as advancing issues outnumbered decliners by a about a 1-to-1 ratio.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nL8N40L1D1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DASX","04333","LU1244550577.SGD","IE00B3CCJ963.GBP","LU1861558580.USD","LU0114720955.EUR","LU1066051811.HKD","BK4532","LU1852331112.SGD","LU0079474960.USD","BK4099","BK4529","LU2362540622.SGD","LU1435385759.SGD","TSLT","IE00BKVL7J92.USD","IE000M9KFDE8.USD","LU2237438978.USD","BK4605","LU0082616367.USD","LU2471134796.USD","BK4555","IE00BGHQF631.EUR","BK4122","LU0203345920.USD","BK4588",".IXIC","LU0957808578.USD","LU0943347566.SGD","LU2543165471.USD","LU1059921491.USD","WDCX","TSII","LU0256863811.USD","ARMG","SGXZ99366536.SGD","ARM","LU1430594728.SGD","LU2417539215.USD","LU2471134952.CNY","LU0689472784.USD","INTC","LU1883839398.USD","LU2602419157.SGD","LU2213496289.HKD","LU1232071149.USD","LU2108987350.USD","IE00B19Z8W00.USD","BK4511","BK4505","07766","LU0672654240.SGD","LU1823568750.SGD","LU1506573853.SGD","LU1629891620.HKD","BK4574","LINT","LU2931357623.SGD","TSLY","LU0077335932.USD","LU2286300806.USD","LU2506951875.HKD","TSLG","LU2362541273.HKD","LU2461242641.AUD","LU1988902786.USD","LU0889565916.HKD","LU2750360997.AUD","SGXZ81514606.USD","TLA","CSCS","TSL","LU0792757196.USD","IE00BQXX3F31.USD","LU2089985449.USD","IE00BWXC8680.SGD","LU2250418816.HKD","BK4612","LU1599440770.SGD","LU0289739699.SGD","LU2237443895.HKD","BK4507","LU0321505868.SGD","TSLQ","BK4516","LU2237443382.USD","LU1066053197.SGD","LU1035773651.USD","REGN","LU2065169927.USD","LU1861215975.USD","IE00B1BXHZ80.USD","LU0820561818.USD","BK4020","DASH","LU0823417737.USD","LU1974910355.USD","BK4566","IE00BMPRXR70.SGD","LU0823417653.USD","LU1814569148.SGD","IE00B42XCP33.USD","LU0964807845.USD","LU0225283273.USD","CSCL","IE0034235303.USD","BK4548","LU1035775433.USD","LU2756315664.SGD","LU0106261372.USD","LU2290526834.HKD","LU2462157665.USD","LU1244550221.USD","LU2236285917.USD","LU0251142724.SGD","IE00BQXX3C00.GBP","LU0889566641.SGD","LU2552382058.USD","LU2552382132.HKD","LU1642822529.SGD","SG9999015952.SGD","IE00BMPRXN33.USD","LU0353189680.USD","NFLW","BK4550","LU2456880835.USD","LU0719512351.SGD","LU1778281490.HKD","LU2247934214.USD","LU1894683348.USD","LU2065171402.SGD","LU2860962120.EUR","LU1880398554.USD","NDX","LU1169590202.USD","LU0466842654.USD","LU2468319806.SGD","LU1267930813.SGD","BK4187","TSDD","BK4533","BK4527","ARMU","LU0234570918.USD","LU1674673691.USD","NFXS","SG9999002224.SGD","LU1551013425.SGD","LU0823434740.USD","LU2420271590.USD","IE00BFMHRM44.USD","LU0006306889.USD","LU0950375773.USD","LU1894683264.USD","LU2506951958.HKD","TSLP","LU1429558221.USD","BK4549","LU2148611432.USD","LU0353189763.USD","LU0882574139.USD","LU1196500208.SGD","LU0708995401.HKD","NFLX","BK4503","LU2087625088.SGD","LU2065170008.USD","LU0320765059.SGD","IE00BVYPNW00.USD","BK4560","LU2249611893.SGD","SG9999001424.SGD","LU1316542783.SGD","LU0256863902.USD","CSCO","IE00B2Q91V27.USD","LU0345769631.USD","IE00B3PB1722.GBP","TSLS","TSYY","TEST","LU2362541513.USD","LU0820562030.AUD","BK4515","LU0316494557.USD","LU0476273544.USD","LU0444971666.USD","TSLZ","LU1585245621.USD","BK4592","LU2237443622.USD","LU2360107168.USD","LU1169589451.USD","BK4609","BK4525","LU0251131958.USD","LU1069347547.HKD","IE00BSNM7G36.USD","LU0868494617.USD","IE00BGHQF524.EUR","BK4108","LU1861559042.SGD","04335","IE00BJLML261.HKD","LU1815336760.USD","LU2750360641.GBP","LU0823434583.USD","LU0882574055.USD","LU2403377893.USD","LU0056508442.USD","LU2237443465.HKD","LU1032955483.USD","LU0444973449.USD","FANG","LU1551013342.USD","CRSH","LU2506952170.USD","LU2896262040.SGD","WDC","BK4524","LU2756315318.SGD","LU0006061336.USD","SG9999015945.SGD","LU1861220033.SGD","LU0868494708.USD","LU0210533765.USD","SGXZ51526630.SGD","LU1917777945.USD","LU2361045086.USD","LU0107464264.USD","LU2506952097.USD","LU2237443549.SGD","LU1244550494.USD","BK4598","LU1066051225.USD","TSLW","LU1839511570.USD","LU0742534661.SGD","LU1046421795.USD","LU2552382215.SGD","SG9999000418.SGD","LU0274383776.USD","TSLA","SG9999002232.USD","IE00BK4W5M84.HKD","GB00BDT5M118.USD","LU1069344957.HKD","IE00B19Z9505.USD","LU0321505439.SGD","LU2237957902.USD","LU0081259029.USD","BK4575","BK4604","IE00BQXX3D17.EUR","LU1880398471.USD","BK4534","LU0731783394.SGD","LU2326559502.SGD","INTW","LU0234572021.USD","LU0823414478.USD","LU0820561909.HKD","LU0048573561.USD","LU0215105999.USD","LU2089984988.USD","LU0345770993.USD","LU0097036916.USD","LU0345770308.USD","NFLU","LU0058720904.USD","SGXZ23171101.USD","LU2237443978.SGD","IE00B19Z8X17.USD","IE00BDGV0183.EUR","BK4579","LU2357305700.SGD","LU1571399168.USD","LU2471134879.HKD","BK4581","LU1064131342.USD","BK4536","LU1548497426.USD","LU0823416689.USD","LU0203201768.USD","NFXL","BK4512","LU0127658192.USD","LU0198837287.USD","IE00BK4W5L77.USD","LU1720051017.SGD","TSLR","BK4585","LU2087621335.USD","LU0098860793.USD","LU1221951046.USD","LU0053666078.USD","IE00BMPRXQ63.HKD","TSLO","LU1720051108.HKD","IE00BKPKM429.USD","AXON","LU2264538146.SGD","BK4209","LU0203202063.USD","BK4551","SG9999015978.USD","LU0642271901.SGD","ARMW","IE00BFXG1179.USD","LU0345769128.USD","TESL","SG9999001440.SGD","LU0203347892.USD","IE00BKDWB100.SGD","LU1914381329.SGD","LU2023250504.SGD","BK4213","BK4602","LU1235294995.USD","LU0323591593.USD","LU1929549753.HKD","IE00B1XK9C88.USD","NFLY","NFLP","LU0417517546.SGD","LU2237957811.SGD","LU0320765992.SGD","TSLL","IE00BVYPNV92.GBP","LU0348723411.USD","SG9999004303.SGD","LU0320765646.SGD","LU1066051498.USD","IE00BZ1G4Q59.USD","LU0109394709.USD","LU1989764664.SGD","LU0786609619.USD","LU1127390331.HKD","BK4554","LU2361044949.HKD","LU2360106780.USD","LU0109391861.USD","LU0823411888.USD","LU1267930730.SGD","HXC","LU2065171311.SGD","LU1221951129.SGD","BK4141","SG9999015986.USD","LU2023250330.USD","LU2361044865.SGD","BK4587","LU1674673428.USD","LU0942090050.USD","LU2471134523.USD","LU1145028129.USD","LU1162221912.USD","BK4170","LU0210536198.USD","TSLI","BK4535","IE00B3T34201.USD","BK4139","LU2102340556.USD","LU2106854487.HKD","LU1366192091.USD","LU2063271972.USD","BK4543"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624597284","title":"Wells Fargo Sticks to Its Hold Rating for Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624597284","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624597284?lang=en_us&edition=fundamental","pubTime":"2026-04-01 18:57","pubTimestamp":1775041044,"startTime":"0","endTime":"0","summary":"In a report released today, Mohit Bansal from Wells Fargo maintained a Hold rating on Regeneron, with a price target of $825.00. Bansal covers the ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wells-fargo-sticks-to-its-hold-rating-for-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wells-fargo-sticks-to-its-hold-rating-for-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623535685","title":"Regeneron Pharma Coverage Assumed by Piper Sandler at Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2623535685","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623535685?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:47","pubTimestamp":1774972020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/REGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 31, 2026 11:47 ET (15:47 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LU0320765992.SGD","LU2362541273.HKD","BK4588","LU0882574055.USD","LU0289739699.SGD","LU2362541513.USD","LU2089984988.USD","LU1917777945.USD","LU2362540622.SGD","BK4585","LU0823434583.USD","LU0823434740.USD","LU0114720955.EUR","LU2023250504.SGD","LU2237438978.USD","BK4139","LU2106854487.HKD","LU0053666078.USD","LU1974910355.USD","LU0823416689.USD","REGN","LU0058720904.USD","LU0889565916.HKD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623353340","title":"Regeneron Pharma Is Maintained at Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2623353340","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623353340?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:29","pubTimestamp":1774970940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/REGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 31, 2026 11:29 ET (15:29 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362540622.SGD","LU0823416689.USD","LU2362541513.USD","LU0114720955.EUR","LU2106854487.HKD","LU0053666078.USD","LU0109394709.USD","LU0823434740.USD","LU0320765992.SGD","LU1974910355.USD","BK4588","LU1917777945.USD","LU2468319806.SGD","LU0289739699.SGD","BK4585","LU0889565916.HKD","LU0882574055.USD","LU2023250504.SGD","BK4139","REGN","LU0823434583.USD","LU2089984988.USD","LU2237438978.USD","LU2362541273.HKD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.regeneron.com","stockEarnings":[{"period":"1week","weight":0.0068},{"period":"1month","weight":-0.0063},{"period":"3month","weight":-0.0186},{"period":"6month","weight":0.2698},{"period":"1year","weight":0.2178},{"period":"ytd","weight":-0.013}],"compareEarnings":[{"period":"1week","weight":0.0166},{"period":"1month","weight":-0.036},{"period":"3month","weight":-0.04},{"period":"6month","weight":-0.02},{"period":"1year","weight":0.1617},{"period":"ytd","weight":-0.0383}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat neovascular age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.514286,"avgChangeRate":0.03675},{"month":2,"riseRate":0.428571,"avgChangeRate":0.086855},{"month":3,"riseRate":0.457143,"avgChangeRate":-0.043382},{"month":4,"riseRate":0.457143,"avgChangeRate":0.016301},{"month":5,"riseRate":0.628571,"avgChangeRate":0.057479},{"month":6,"riseRate":0.428571,"avgChangeRate":0.006745},{"month":7,"riseRate":0.657143,"avgChangeRate":0.052646},{"month":8,"riseRate":0.542857,"avgChangeRate":0.022877},{"month":9,"riseRate":0.457143,"avgChangeRate":0.023281},{"month":10,"riseRate":0.4,"avgChangeRate":-0.00141},{"month":11,"riseRate":0.542857,"avgChangeRate":0.046018},{"month":12,"riseRate":0.485714,"avgChangeRate":0.043803}],"exchange":"NASDAQ","name":"Regeneron Pharmaceuticals","nameEN":"Regeneron Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Regeneron Pharmaceuticals(REGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Regeneron Pharmaceuticals(REGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Regeneron Pharmaceuticals,REGN,Regeneron Pharmaceuticals股票,Regeneron Pharmaceuticals股票老虎,Regeneron Pharmaceuticals股票老虎国际,Regeneron Pharmaceuticals行情,Regeneron Pharmaceuticals股票行情,Regeneron Pharmaceuticals股价,Regeneron Pharmaceuticals股市,Regeneron Pharmaceuticals股票价格,Regeneron Pharmaceuticals股票交易,Regeneron Pharmaceuticals股票购买,Regeneron Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Regeneron Pharmaceuticals(REGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Regeneron Pharmaceuticals(REGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction